Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
CURRENT ASSETS:
Cash and cash equivalents	$ 54,342	$ 76,692
Marketable Securities	48,427	41,118
Accounts receivable, net	15,422	9,643
Other current assets	2,476	2,729
Total current assets	120,667	130,182
Fixed assets, net	10,136	6,259
Other long-term assets	1,983	2,236
Total assets	132,786	138,677
CURRENT LIABILITIES:
Accounts payable	8,618	7,710
Accrued expenses and other current liabilities	7,056	8,031
Deferred revenues	2,866	3,282
Total current liabilities	18,540	19,023
Warrant liabilities	862	1,690
Other long-term liabilities	443	569
Total liabilities	19,845	21,282
Commitments and contingencies (Note 6)
STOCKHOLDERS' EQUITY:
Common stock of $0.0001 par value per share: Shares authorized: 1,000,000,000 as of June 30, 2025 (unaudited) and December 31, 2024; shares issued and outstanding: 167,944,188 and 168,849,591 as of June 30, 2025 (unaudited) and December 31, 2024, respectively.	17	17
Additional paid-in capital	382,364	386,612
Accumulated deficit	(269,459)	(269,236)
Accumulated other comprehensive income	19	2
Total stockholders' equity	112,941	117,395
Total liabilities and stockholders' equity	$ 132,786	$ 138,677